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1. Introduction
A traditional view on probiotics is that the administrated, 
live microorganism shall bring ‘balance’ to the intestinal 
microbiota and mitigate adverse bacteria (Fuller, 1989; 
Parker, 1974). Balance can also be interpreted in terms 
of high alpha-diversity. In contrast, examples of adverse 
components of the intestinal microbiota, that can cause 
overgrowth and, hence, severely decreased diversity are 
genera of the family Enterobacteriaceae, and in mammalians 
especially the species Escherichia coli. Pro-inflammatory 
lipopolysaccharides (LPS) are associated to the cell surface 
of E. coli (Poxton and Edmond, 1995). Furthermore, specific 
strains of E. coli can also be invasive, enterotoxin producing, 
and carrier of multiple antibiotic resistance genes. One 
example of an adverse effect of commonplace E. coli, is that 
early colonisation in infants increases the risk for atopic 
eczema later in life (Penders et al., 2007), and the same 
effect has low diversity, early in life (Abrahamsson et al., 
2012; Ismail et al., 2012; Wang et al., 2008). It has also 
been observed that Enterobacteriaceae are abundant in 
the colonic mucosa of patients suffering from diverticular 
disease (Linninge et al., 2018). A clinically problem of 
considerable magnitude involving E. coli is urinary tract 
infections (UTIs) where it has been seen that uropathogenic 
E. coli often dominates the faecal microbiota of the 
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Abstract
Probiotics should bring ‘balance’ to the intestinal microbiota by stimulating beneficial bacteria, whilst mitigating 
adverse ones. Balance can also be interpreted as high alpha-diversity. Contrary, Escherichia coli is often regarded 
as an adverse component of the resident intestinal microbiota. The aim of the present study was to implement 
a mouse model for in vivo screening of Lactobacillus-strains for ability to increase gut-microbiota diversity and 
to mitigate E. coli. Mice were divided into six groups, two dietary control-groups and four groups administered 
strains of Lactobacillus fermentum and/or Lactobacillus plantarum. All animals were pre-treated with antibiotics, 
and E. coli in order to equalise the microbiota from the start. After 7 weeks of Lactobacillus administration, the 
animals were sacrificed: DNA was extracted from caecum tissue, and the microbiota composition was analysed 
with terminal restriction fragment length polymorphism (T-RFLP) and 16S rRNA gene sequencing. The diversity of 
the caecal microbiota decreased when the dietary carbohydrate source was limited to corn starch. Conversely, the 
diversity was restored by Lactobacillus-supplements. The tested combinations of two Lactobacillus strains exerted 
different influences, not only on the taxonomic level, but also on the inferred microbiome functions. The mixture 
of L. fermentum GOS47 and L. fermentum GOS1 showed potential for anti-inflammatory activity and short chain 
fatty acid production. On the other hand, co-administration of L. fermentum GOS57 and L. plantarum GOS42 
significantly decreased the viable count of Enterobacteriaceae. These results warrant further investigation of the 
tested strains as candidates for probiotics. Furthermore, the findings demonstrated that the current experimental 
animal model is suitable for in vivo studies of the effect of bacterial supplements on the gut-microbiota.
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patients (Yamamoto et al., 1997). Uropathogenic E. coli 
has a capacity to migrate from the intestinal tract to the 
urinary tract, and E. coli is the infecting agent in about 
80% of all UTIs, (Hooton and Stamm, 1997; Svanborg 
and Godaly, 1997). Uropathogenic strains of E. coli with 
multiple antibiotic resistance is of special public concern, 
because such infection can’t be efficiently treated with 
antibiotics. Mouse-models are frequently used in preclinical 
investigations. For example, colitis in mouse strongly 
alter the colonic microbiota (Håkansson et al., 2015) and 
increases the abundance of Enterobacteriaceae (Constante 
et al., 2017). Another mouse model was used for in vivo 
verification of a potential probiotic strain selected by in vitro 
tests (Silva et al., 2016), but the promising achievements 
failed to deliver in vivo.
The aim of the present study was to implement a mouse 
model for in vivo screening of different Lactobacillus-
strains with probiotic potential, and search for strains able 
to increase microbiota diversity and to reduce the relative 
abundance of Enterobacteriaceae in vivo. The applied mouse 
model has previously been developed for this purpose 
(Linninge et al., 2015). The gut microbiota between different 
animals is in the model initially equalised by a short 
antibiotic pre-treatment followed by E. coli administration. 
Three novel strains of Lactobacillus fermentum and one 
of Lactobacillus plantarum were tested in combinations, 
in order to minimise the number of animals. The test-
strains were compared with the scientifically established, 
and commercially available probiotic strain L. plantarum 
299v (Molin, 2008). The caecal microbiota composition 
and diversity of the mice was investigated by 16S rRNA 
gene sequencing and terminal restriction fragment length 
polymorphism (T-RFLP).
2. Material and methods
Experimental set-up
Male C57BL/6NCrl mice, 8 weeks old with body weight 18.9 
to 22.5 g, were purchased from Charles River laboratories 
(Sulzfeld, Germany), and randomly divided into six groups 
(eight animals/group; one cage/group). The animals were 
maintained in a temperature-controlled environment on a 
12-h light/dark cycle. All experiments followed the national 
guidelines for the care and use of animals, and the study was 
approved by the Malmö/Lund regional ethics committee 
for laboratory animals (ethical permission, M209-11). All 
animals were pre-treated according to Linninge et al. (2015) 
in order to equalise the microbiota before the beginning of 
the test-series. Briefly, an antibiotic cocktail of ampicillin, 
metronidazole and clindamycin was given daily for three 
days in the drinking water (Linninge et al., 2015). The 
antibiotics were consumed at clinical relevant doses. Two 
non-pathogenic strains of E. coli were then given in the 
drinking water, for two days (Linninge et al., 2015). Water 
consumption was determined daily, and an average dose of 
108 cfu of each E. coli strain was consumed by each mouse.
Diet and bacterial supplementation
The widely used and well-known, purified rodent diet 
AIN-76A was given to one group, while five groups were 
given a custom designed, purified open source, corn 
starch diet (CS-ctrl diet); with the intention to stimulate 
Enterobacteriaceae in the gut. The general composition of 
the CS-diet is based on AIN-76A. Both diets had an energy 
composition of 20.8 E% protein, 67.7 E% carbohydrates 
and 11.5 E% fat, and corn oil is the source of fat in both 
diets. The carbohydrates are provided by corn starch and 
sucrose in AIN-76A, while the sucrose was replaced by 
additional corn starch in the CS-diet; the total amount of 
carbohydrates was the same in both diets. Both diets were 
produced by Research Diets (New Brunswick, NJ, USA). 
The CS-ctrl diet was previously composed by Linninge 
et al. (2015) and was called ‘research diet’ (RD). Feed was 
administered ad libitum. After the five days pre-treatment, 
animals were given different Lactobacillus-strains in the 
drinking water for seven weeks according to Table 1.
The novel strains of L. fermentum GOS47, L. fermentum 
GOS1, L. fermentum GOS57 and L. plantarum GOS42 (= 
DSM 32131) have all been isolated from human saliva of 
healthy young adults. L. plantarum 299v was originally 
isolated from healthy human intestinal mucosa (Molin et al., 
1993). The Lactobacillus-strains were supplemented in the 
drinking water. Drinking water with bacterial supplement 
was changed daily; each animal consumed 5×107 to 1×108 
cfu of Lactobacillus per day.
Animal sacrifice and sampling
After seven weeks with bacterial supplementation in the 
drinking water, animals were sacrificed by CO2 inhalation. 
The abdomen and chest were opened and spleen, liver, 
Table 1. Dietary regime and bacterial supplements.
Group Diet1 Bacterial strains 
AIN-76A AIN-76A -
CS-ctrl CS -
299v CS Lactobacillus plantarum 299v
LF CS Lactobacillus fermentum GOS47 + L. fermentum 
GOS1
LP CS L. fermentum GOS57, L. plantarum GOS42
LFP CS GOS47 + GOS1 + GOS57 + GOS42
1 AIN-76A is a traditional, purified rodent diet; CS is a custom designed, 
purified open source diet where the sucrose in AIN-76A had been replaced 
by corn starch.
Please cite this article as 'in press'  Beneficial Microbes 
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small intestine (SI), caecum and epididymal fat pads were 
carefully dissected and weighed. Caecum tissue (rinsed in 
sterile PBS) and caecum content (stored in glycerol buffer; 
Karlsson et al., 2011b) were immediately frozen on dry ice, 
and then stored at -80 °C until analysis.
DNA extraction
DNA from caecum tissue was extracted according to Sand 
et al. (2015) with the modification that 100 µl Phosphate 
Buffered Saline (PBS, Oxoid, Basingstoke, UK) was added to 
100 µl supernatant before extraction in the EZ1 Advanced 
XL and eluted in 200 µl.
Terminal restriction fragment length polymorphism
Endpoint PCR was performed in a reaction of 25 µl, 
including 1-3 µl template, for 25 cycles according to 
Sand et al. (2015). Terminal restriction fragment length 
polymorphism (T-RFLP) analysis including digestion 
with the restriction endonuclease MspI was performed 
as previously described (Sand et al., 2015). Thresholds for 
internal standard and terminal restriction fragments (T-RFs) 
were set to 20 and 40 fluorescence units, respectively.
Next generation sequencing
Next generation sequencing of the gut microbiota was 
performed using ion torrent sequencing with the Ion 
Torrent PGM platform (Life Technologies, Carlsbad, CA, 
USA) at the Technical University of Denmark (DTU) core 
facility (Lyngby, Denmark), in accordance with Sand et al. 
(2015). The primers were the same as used by Tulstrup 
et al. (2015), which were targeting V3 region of the 16S 
rRNA gene. The PCR reactions were conducted with 4 
µl HF-buffer, 0.4 µl dNTP (10 mM of each base), 1 µM 
forward primer, 1 µM reverse primer, 5 ng template DNA, 
and 0.2 µl Phusion High-Fidelity DNA polymerase (F-530S, 
Thermo Scientific, Waltham, MA, USA) in a total reaction 
volume of 20 µl.
Sequences were demultiplexed and primers were removed 
using CLC bio genomic workbench (Qiagen, Hilden, 
Germany). Further quality trimming was performed using 
default settings (quality score = 0.05, trim ambiguous 
nucleotides = 2) only reads with a final length between 110-
180 bp were kept for downstream analysis. The number of 
good quality reads used for taxonomical assignment ranged 
from 19,225 to 98,494 per sample. The filtered sequences 
were then processed with an open source bioinformatics 
tool QIIME2 (https://qiime2.org/) (Caporaso et al., 2010). 
The sequences were further denoised with Qiime 2 plugin 
dada2 (Callahan et al., 2016). The resulting amplicon 
sequence variants (ASVs) were used for diversity analyses 
(alpha and beta) and taxonomic classification. The Naïve 
Bayes classifier was trained on V3 region sequences of 
Greengenes 13_8 release (99% operational taxonomic 
units (OTUs)) (DeSantis et al., 2006) using QIIME2 plugin 
feature-classifier. Subsequent multivariate data analyses 
were performed at Calypso online web-server (Zakrzewski, 
2017). Besides the taxonomic profiling, inferred 
metagenomes were predicted using PICRUSt (version 
1.1.2) (Langille et al., 2013). The predicted metagenome 
was further analysed with HUMAnN 0.99 (Abubucker et 
al., 2012) and statistical analyses were performed using 
STAMP v2.1.3 (Parks et al., 2014).
Quantitative PCR
Bacterial abundance of: total bacteria, the Clostridium 
leptum-group, the Bacteroides fragilis-group and the family 
Enterobacteriaceae were estimated in caecal tissue using 
separate quantitative PCR assays as previously described 
(Karlsson et al., 2011a; Linninge et al., 2015). Detection 
limit was 104 copies of 16S rRNA genes/reaction for total 
bacteria, 102 copies of 16S rRNA genes/reaction for both 
the C. leptum-group and Enterobacteriaceae. The B. fragilis-
group had a detection limit of 103 copies/reaction. Samples 
below detection limit were set to the lowest detection 
limit for each specific assay. For standard curves, 10-fold 
dilution series of the target DNA were made in EB-buffer 
(Qiagen). Bacterial numbers were expressed as log10 16S 
rRNA genes/g caecum tissue.
Viable count of Enterobacteriaceae and lactobacilli
Caecum content was thawed and homogenised in glycerol 
buffer (Karlsson et al., 2011b) containing freezing medium, 
diluted and plated on Rogosa agar (Oxoid Ltd.) and 
incubated anaerobically at 37 °C for 72 h for lactobacilli 
count, and plated on violet red bile dextrose agar 
(VRBD), and incubated aerobically at 37 °C for 24 h for 
Enterobacteriaceae count (Merck, Darmstadt, Germany).
Calculations
Bacterial diversity based on T-RFLP was estimated by 
calculation of richness (number of T-RFs) and Shannon and 
Simpson diversity indices as previously described (Sand et 
al., 2015). Statistical analyses were performed in GraphPad 
Prism 7 (La Jolla, CA, USA) using Kruskal-Wallis test and 
Dunn’s multiple comparisons test to reveal differences 
compared to group CS-ctrl. P<0.05 was considered 
statistically significant. Statistical analyses on the 16S 
amplicon data and the inferred metagenome data obtained 
by PICRUSt (Langgille et al., 2013) were performed at 
Calypso online web-server (Zakrzewski, 2017).
 Please cite this article as 'in press'
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3. Results
Animal status
The pre-treatment with antibiotics and E. coli were well 
tolerated by all animals. No adverse effects were observed, 
and no signs of disease occurred during the experimental 
period. In group LFP, one animal was injured, probably by 
other animals; the injured animal was removed from the 
cage and excluded from the study. No difference in feed 
consumption was observed between the groups. Animals 
of the control group with the CS-diet, and without any 
Lactobacillus supplementation (CS-ctrl), had a significantly 
(P<0.05) lighter small intestine than animals of the AIN-76 
diet. No other statistically significant differences in animal 
constitution were seen between the different test groups 
(Table 2).
Microbiota
The sequencing failed in two samples, one from group 
AIN-76A and one from CS-ctrl, and therefore these mice 
were removed from the sequencing analysis. Lactobacillus 
supplementation increased the diversity of the microbiota 
and changed its structure: Firmicutes and Bacteroidetes 
were the most dominating phyla followed by Actinobacteria 
in all groups, while Tenericutes were more abundant in 
the two dietary control groups without Lactobacillus 
supplementation (AIN-76 and CS-ctrl, respectively; Figure 
1). Abundant taxa differed between the groups: At the 
hierarchical levels of family and of genus distinctive clusters 
were formed (Figure 2). Different bacterial genera were 
found statistically enriched with large effect size, between 
the animal groups (Figure 3). For example, Bifidobacterium 
was favoured in the group 299v, and Lactobacillus 
abundance was highest in the LP group (Figure 3).
Table 2. Median values, and interquartile ranges, of body and organ weights of mice in different test groups.1
Weight (g) Animal groups2
AIN-76A CS-ctrl 299v LF LP LFP
Body 29 (28.7-31.3) 27.1 (26.6-27.8) 28.1 (25.6-28.7) 28.1 (27.2-29.8) 27.6 (26.527.9) 26.2 (25.6-28.7)
Spleen 0.070 (0.067-0.087) 0.064 (0.063-0.073) 0.064 (0.062-0.068) 0.066 (0.064-0.072) 0.073 (0.064-0.084) 0.063 (0.061-0.072)
Liver 1.4 (1.31-1.51) 1.27 (1.20-1.38) 1.19 (1.04-1.30) 1.21 (1.17-1.28) 1.19 (1.01-1.26) 1.12 (1.10-1.19)
Epidymal fat pad 0.757 (0.548-0.936) 0.628 (0.528-0.790) 0.607 (0.494-0.754) 0.597 (0.435-0.772) 0.464 (0.385-0.664) 0.463 (0.41-0.536)
Small intestine 0.035* (0.032-0.042) 0.025 (0.019-0.028) 0.024 (0.021-0.026) 0.030 (0.024-0.033) 0.030 (0.024-0.033) 0.023 (0.021-0.025)
Caecum 0.239 (0.218-0.264) 0.264 (0.235-0.271) 0.266 (0.231-0.285) 0.263 (0.233-0.286) 0.275 (0.221-0.328) 0.275 (0.218-0.306)
1 An asterisk denotes statistically significant difference compared to CS-ctrl, P<0.05.
2 Animal diet groups are explained in Table 1.
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Figure 1. Bar plot of relative abundance of the mice caecal microbiota at phylum level. Horizontal greyscale code bars at the 
top indicate the different treatment groups. One bar corresponds to one mouse and numerical numbers are the randomisation 
identities of the animals.
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The dietary change in carbohydrate source, where sucrose 
was replaced by corn starch, decreased the microbiota 
diversity in the CS-ctrl group, while Lactobacillus 
supplementation restored the diversity (Table 3). There was 
also a significant difference in the beta diversity between 
the six treatment groups (P<0.001, PERMANOVA on Bray 
Curtis distances, Figure 4).
Lactobacillus supplementation increased the lactobacilli 
population and suppressed Enterobacteriaceae, but the 
total amount of bacterial 16S rRNA genes in caecum 
tissue, and the number of genes in the C. leptum group 
did not differ depending on dietary regime or bacterial 
supplement (Table 3). 16S rRNA genes of Bacteroides 
fragilis were not detectable in any of the groups. No 
16S rRNA genes of Enterobacteriaceae were found in 
groups AIN-76A, 299v, LF, LP and LFP. 16S rRNA genes 
of Enterobacteriaceae above the detection limit of PCR, 
could only be quantified in the CS-ctrl group. The amount 
corresponded to log 6.81 16S rRNA gene copies/gram 
caecum tissue, with an interquartile range of 6.24-7.3. In 
contrast, Enterobacteriaceae enumerated by viable count 
were found in all groups, indicating a certain effect of 
the pre-treatment procedure. Viable count had a lower 
detection level than PCR in the present settings. The 
supplementation of L. fermentum GOS57 + L. plantarum 
GOS42 in group LP resulted in a significant decrease in 
the number of Enterobacteriaceae, compared to CS-ctrl 
group (Table 3).
Supplementation of Lactobacillus in groups 299v, LF and 
LP significantly increased the viable count of lactobacilli 
in caecum content (Table 3). Lactobacilli of non-probiotic 
origin were found in the AIN-76A group, while the CS-ctrl 
group lacked detectable lactobacilli, which also was one 
purpose of the pre-treatment procedure of the animals.
Microbiome
Inferred microbiome functions differed between groups: 
Inferred metagenomic profiles were different between 
the two dietary control groups, but also between groups 
supplemented with different Lactobacillus strains (Figure 
5). Ten KEGG pathways and six KEGG modules were 
significantly different between AIN-76 and CS-ctrl (Figure 
6). After observing the considerable differences between 
the two control groups, the Lactobacillus supplemented 
groups were compared with CS-ctrl. Abundance of 15 
KEGG pathways and 16 KEGG modules were significantly 
different with large effect size (Table 4). For instance, 
pathways involved in the short chain fatty acids (SCFAs) 
production (Ko00620, ko00640) were enriched in the 
LF and 299v groups compared to CS-ctrl. On the other 
hand, multiple sugar transport system (M00207) was most 
abundant in the CS-ctrl group.
Phylum 
PC1 (70%)
PC
2 
(1
6%
)
Bacteroidetes
Actinobacteria
FirmicutesTenericutes
TM7
VerrucomicrobiaProteobacteria
Family 
PC1 (34%)
PC
2 
(3
0%
)
S247
Bacteroidaceae
Porphyromonadaceae
Lachnospiraceae
Unclassified.Clostridiales
Anaeroplasmataceae
Rikenellaceae
Turicibacteraceae
Ruminococcaceae
Peptococcaceae
Genus 
A 
3
1
0
-1
-2
2
1
0
-1
-2
2 
-3
-2 -1 0 1 2
-2 -1 0 1
-2 -1 0 1
1 
0 
-1 
-2 
-3 
B 
C 
PC1 (35%)
PC
2 
(2
8%
)
Moryella
Unclassified.S247
BacteroidesUnclassified.Clostridiales
Parabacteroides
Anaeroplasma
Unclassified.RikenellaceaeTuricibacter
rc44Lactobacillus
AIN_76A
CS_ctrl
LF
LFP
LP
Lp299v
Figure 2. Principal component analysis (PCA) of the relative 
abundance of mice caecal microbiota at different hierarchical 
levels. One dot represent one animal and different diet groups 
are shown with different greyscales. The location of the taxa 
shows how those bacteria drive the separation of the groups.
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Bifidobacterium
Unclassified_F16
Blautia
Adlercreutzia
Parabacteroides
Unclassified_Rikenellaceae
Lactobacillus
Dehalobacterium
Unclassified_S247
Turicibacter
rc44
Unclassified_Lachnospiraceae
Moryella
Ethanoligenens
Oribacterium
Allobaculum
Bacteroides
Unclassified_Clostridiales
Anaeroplasma
Unclassified_Mogibacteriaceae
Lactococcus
Coprobacillus
Akkermansia
Clostridium
Oscillospira
Unclassified
Ruminococcus
Dorea
Unclassified_Ruminococcaceae
LDA score (log 10)
0 1 2 3 4 5
AIN_76A
CS_ctrl
LF
LFP
LP
Lp299v
Figure 3. Significantly enriched genera among the tested six groups revealed by linear discriminant analysis coupled with effect 
size (LEFSe). Statistical significance was set to P<0.05 and LDA>3.0.
Table 3. Diversity based on next generation sequencing (NGS) and terminal restriction fragment length polymorphism (T-RFLP), 
quantification of 16S rRNA genes and viable count in different test groups.1
Animal groups2
AIN-76A CS-ctrl 299v LF LP LFP
Diversity
Richness (T-RFLP) 10.5 (5.25-15.3) 9 (8-15) 23* (13-26) 17 (15-20) 20.5** (17.8-23.5) 14 (12-17)
Cho 1 (NGS) 97 (89-103) 83 (75-91) 94 (87.8-94.8) 105* (97.1-108) 101 (85.5-108) 118** (96-121)
Shannon diversity 
index (T-RFLP)
2.08 (1.32-2.35) 1.87 (1.61-2.30) 2.34 (2.16-2.87) 2.43* (2.37-2.58) 2.68*** (2.54-2.75) 2.34 (1.92-2.41)
Shannon diversity 
Index (NGS)
5.23** (5.17-5.38) 4.73 (4.62-4.82) 5.19* (5.09-5.34) 4.71 (4.49-4.99) 4.95 (4.86-5.09) 5.54** (4.93-5.84)
Simpson diversity 
index (T-RFLP)
0.826 (0.667-.866) 0.792 (0.714-.842) 0.858 (0.826-.923) 0.884* (0.863-.905) 0.903*** (0.891-.918) 0.848 (0.772-.892)
Simpson diversity 
index (NGS)
0.96* (0.95-0.96) 0.94 (0.92-0.94) 0.95 (0.94-0.96) 0.89 (0.87-0.93) 0.94 (0.94-0.95) 0.97* (0.94-0.97)
Quantification of 16S 
rDNA (copies/g tissue)
Total bacteria 8.68 (8.41-8.79) 8.95 (8.76-9.04) 8.70 (8.56-9.01) 9.15 (9.00-9.36) 9.05 (8.94-9.21) 8.92 (8.80-9.05)
Clostridium leptum 7.12 (6.81-7.27) 7.03 (6.97-7.19) 6.92 (6.68-7.04) 9.15 (9.00-9.36) 9.05 (8.94-9.21) 8.92 (8.80-9.05)
Viable count (log cfu/g 
caecum content)
Lactobacilli 5.72* (5.18-5.98) 0 (0-0) 6.48**** (6.37-6.59) 5.59* (4.99-6.14) 6.18*** (5.90-6.57) 4.93 (3.55-5.64)
Enterobacteriaceae 2.95 (1.97-3.64) 3.62 (3.29-4.09) 3.73 (3.37-4.17) 3.26 (2.80-3.54) 2.63* (2.37-2.89) 2.3 (0-3.50)
1 Median values, and interquartile ranges within parenthesis are presented. Asterisks denote significantly different compared to the CS-ctrl group, * 
P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001.
2 Animal diet groups are explained in Table 1.
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4. Discussion
The mouse model used in the present study was developed 
with the primary goal to build an in vivo, screening 
model for the evaluation of potentially probiotic strains 
of Lactobacillus (Linninge et al., 2015). Requirements 
for the model included (1) the natural microbiota of the 
individual animals should be as uniform as possible, (2) 
the spontaneously occurring Lactobacillaceae should 
be minimised, and (3) all animals should from the start 
harbour substantial amounts of Enterobacteriaceae. All 
these demands have been fulfilled by the model: The 
individual differences in microbiota within each group were 
considerably smaller than that between the different groups 
(Figure 2 and 4). No lactobacilli, but a measurable amount of 
Enterobacteriaceae, were detected by viable count in the CS-
ctrl, diet control group (Table 3). Furthermore, in contrast 
to the conventional AIN-76A diet, the CS-ctrl diet favoured 
other components of the microbiota, e.g. the gram-negative 
families Bacteroidaceae and Porphyromonadaceae (data 
not shown).
A limitation of the present model-design is that animals 
given different bacterial supplements cannot be maintained 
in the same cage, i.e. a certain ‘cage effect’ cannot be ruled 
out in the present study design. However, the microbiota 
of individual mice living in the same cage, under more 
conventional circumstances can differ widely in spite of the 
same cage-environment. At the same time, the condition of 
the present model strongly equalises the microbiota from 
the start, which should minimise individual differences 
(Linninge et al., 2015). Thus, the risk of a cage-effect is 
somewhat decreased by the selective power of the model. 
The fact that the animals in groups CS-ctrl and 299v cluster 
so closely together, while the other groups are so different, 
points in the same direction, i.e. that the eventual cage-
effect seems to be of secondary importance (Figure 4).
A highly interesting feature for probiotics is the ability 
to induce increased diversity of the gut-microbiota. 
Despite the difference in resolution capacity between 
the T-RFLP and NGS, the diversity estimation of the 
caecal microbiota points in the same direction. All the 
Lactobacillus-supplemented groups showed, statistically 
significant increase in alpha diversity in either T-RFLP, 
NGS or both analysis (Table 3). Regarding the beta-diversity 
(Figure 4), it was observed that the effect from probiotic 
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Figure 4. Principal coordinates analysis (PCoA) of beta diversity 
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strain L. plantarum 299v differed largely from the other 
Lactobacillus supplemented groups and was more similar 
to the two control groups. This indicates that just a smaller 
change in the dominant bacterial taxa was induced by L. 
plantarum 299v. In contrast, the Shannon diversity index 
was significantly increased (Table 3), which indicates 
that the number of rare taxa had increased in the 299v 
group. The 299v-supplement favoured bifidobacteria to 
highest degree (Figure 3) but showed no effect against 
Enterobacteriaceae (Table 3).
Generally, the three tested combinations of novel strain-
supplementations influenced the microbiota in a way 
different from L. plantarum 299v (Figure 4), indicating strain 
specific effects. The observed differences in microbiota 
between animals in group LPF seem to be imposed by 
another parameter than the supplementation of the mixture 
of all four strains (group LFP). The heterogeneity within the 
LPF-group may be a result of stress as one of the animals 
was found injured and had to be taken away; maybe the 
stress was due to aggression between certain animals in 
this particular group. No significant changes in the viable 
count of lactobacilli and Enterobacteriaceae could be seen 
in this disturbed group (group LPF) compared to group 
CS-ctrl (Table 3).
The strain specific effects were not limited to the influence 
on the bacterial members of the microbiota, but also to the 
inferred microbiome functions (Figure 5). Interestingly, a 
change in the sort of dietary carbohydrate in CS-ctrl led 
to a substantial change in microbiome functions (Figure 
6). Bacterial functions involved in glycosaminoglycan 
degradation (Ko00531) and LPS biosynthesis (Ko00540) 
were enriched when the diet carbohydrate source was 
only corn starch. On the contrary, LF suppressed these 
two pathways (Figure 7). Bacterial glycosaminoglycan 
degradation has been linked to inflammatory bowel disease 
in both animals and humans (Lee et al., 2009; Murch 
et al., 1993). LPS is well known to induce production 
of proinflammatory mediators. Furthermore, LF had 
significantly enriched pathways involved in the SCFA 
production. Thus L. fermentum GOS47 and L. fermentum 
GOS1 should be considered for further investigations as 
candidate probiotics. On the other hand, the viable count 
A
B
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Figure 6. Extended error bar plot showing significantly different abundant KEGG pathways (A) and modules (B) between AIN-76A 
and CS-ctrl. P-values are corrected with Bonferroni correction.
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of Enterobacteriaceae was significantly decreased only 
in group LP, which can be a highly beneficial trait for a 
potential probiotic strain. The question remains whether 
the observed effect requires the presence of both strains, 
Table 4. Significantly enriched KEGG pathways and modules with large effect size (η2>0.80). P-values were corrected with 
Bonferroni correction.1
KEGG pathwyas P-values 
(corrected)
Effect 
size
Animal groups2
CS-ctrl LF LFP LP Lp299v
ko00660: C5-Branched dibasic acid metabolism 2.55E-15 092 2.43 (0.03) 2.71 (0.03) 2.35 (0.06) 2.41 (0.04) 2.39 (0.02)
ko00730: Thiamine metabolism 1.14E-13 090 1.7 (0.02) 2.11 (0.06) 1.9 (0.06) 1.82 (0.05) 1.94 (0.03)
ko00253: Tetracycline biosynthesis 1.45E-13 090 0.52 (0.02) 0.91 (0.05) 0.63 (0.06) 0.6 (0.06) 0.71 (0.02)
ko00061: Fatty acid biosynthesis 1.29E-12 088 1.36 (0.02) 1.8 (0.07) 1.49 (0.07) 1.47 (0.06) 1.58 (0.03)
ko00290: Valine, leucine and isoleucine biosynthesis 1.31E-12 088 2.65 (0.03) 2.83 (0.02) 2.62 (0.04) 2.67 (0.02) 2.68 (0.01)
ko00550: Peptidoglycan biosynthesis 3.62E-12 087 1.65 (0.02) 1.86 (0.04) 1.76 (0.03) 1.72 (0.02) 1.76 (0.02)
ko00640: Propanoate metabolism 7.65E-12 087 0.6 (0.01) 0.69 (0.02) 0.6 (0.02) 0.58 (0.02) 0.65 (0.01)
ko00620: Pyruvate metabolism 5.85E-11 085 1.2 (0.01) 1.27 (0.01) 1.21 (0.02) 1.21 (0.01) 1.26 (0.01)
ko00270: Cysteine and methionine metabolism 5.26E-10 083 1.18 (0.01) 1.31 (0.01) 1.26 (0.03) 1.23 (0.03) 1.3 (0.02)
ko00400: Phenylalanine, tyrosine and tryptophan 
biosynthesis
7.28E-10 083 1.11 (0.02) 1.27 (0.02) 1.17 (0.06) 1.11 (0.02) 1.24 (0.01)
ko00195: Photosynthesis 1.44E-09 082 0.45 (0.02) 0.52 (0.01) 0.47 (0.02) 0.44 (0.02) 0.49 (0.01)
ko00900: Terpenoid backbone biosynthesis 2.63E-09 081 1.1 (0.02) 1.47 (0.06) 1.3 (0.09) 1.26 (0.07) 1.33 (0.02)
ko00785: Lipoic acid metabolism 3.49E-09 081 0.73 (0.07) 0.37 (0.05) 0.69 (0.06) 0.74 (0.1) 0.6 (0.04)
ko00471: D-Glutamine and D-glutamate metabolism 5.81E-09 080 1.62 (0.02) 1.97 (0.05) 1.84 (0.09) 1.82 (0.07) 1.87 (0.02)
ko00760: Nicotinate and nicotinamide metabolism 6.90E-09 080 0.83 (0.01) 1.03 (0.02) 0.92 (0.05) 0.89 (0.04) 0.9 (0.02)
KEGG modules
M00222: Phosphate transport system 5.09E-13 089 2.72 (0.02) 3.31 (0.09) 2.73 (0.14) 2.58 (0.07) 2.57 (0.13)
M00157: F-type ATPase, bacteria 5.70E-13 089 2.81 (0.07) 3.43 (0.09) 2.85 (0.15) 2.61 (0.11) 3.14 (0.09)
M00164: ATP synthase 5.70E-13 089 2.81 (0.07) 3.43 (0.09) 2.85 (0.15) 2.61 (0.11) 3.14 (0.09)
M00001: Glycolysis (Embden-Meyerhof pathway), 
glucose => pyruvate
1.39E-12 088 3.85 (0.07) 4.47 (0.1) 3.87 (0.12) 3.84 (0.1) 4.17 (0.06)
M00022: Shikimate pathway, phosphoenolpyruvate + 
erythrose-4P => chorismate
2.65E-12 088 2.17 (0.04) 3.1 (0.12) 2.54 (0.16) 2.34 (0.18) 2.88 (0.07)
M00002: Glycolysis, core module involving  
three-carbon compounds
1.00E-11 087 3.33 (0.08) 3.87 (0.09) 3.4 (0.09) 3.34 (0.1) 3.64 (0.05)
M00359: Aminoacyl-tRNA biosynthesis, eukaryotes 1.18E-11 087 2.78 (0.06) 3.36 (0.1) 2.87 (0.11) 2.81 (0.11) 3.14 (0.04)
M00360: Aminoacyl-tRNA biosynthesis, prokaryotes 1.48E-11 086 2.81 (0.06) 3.37 (0.1) 2.9 (0.1) 2.84 (0.1) 3.17 (0.05)
M00007: Pentose phosphate pathway, non-oxidative 
phase, fructose 6P => ribose 5P
2.39E-11 086 3.14 (0.09) 4.21 (0.13) 3.4 (0.2) 3.26 (0.24) 3.82 (0.08)
M00115: NAD biosynthesis, aspartate => NAD 1.34E-10 084 1.51 (0.1) 2.84 (0.14) 2.06 (0.27) 1.87 (0.26) 2.03 (0.1)
M00178: Ribosome, bacteria 2.80E-10 084 2.56 (0.08) 3.2 (0.11) 2.74 (0.11) 2.67 (0.12) 2.92 (0.04)
M00006: Pentose phosphate pathway, oxidative 
phase, glucose 6P => ribulose 5P
4.79E-10 083 1.86 (0.08) 0.6 (0.12) 1.07 (0.26) 1.41 (0.28) 1.04 (0.09)
M00026: Histidine biosynthesis, PRPP => histidine 7.18E-10 083 2.66 (0.06) 3.33 (0.1) 2.73 (0.17) 2.71 (0.13) 2.61 (0.13)
M00004: Pentose phosphate pathway  
(Pentose phosphate cycle)
1.19E-09 082 2.33 (0.07) 1.05 (0.18) 1.6 (0.26) 1.94 (0.27) 1.63 (0.12)
M00207: Multiple sugar transport system 2.74E-09 081 5.81 (0.57) 1.75 (0.46) 2.86 (0.92) 3.95 (0.89) 2.42 (0.31)
M00003: Gluconeogenesis, oxaloacetate => 
fructose-6P
4.02E-09 081 3.22 (0.09) 3.68 (0.1) 3.03 (0.21) 3.01 (0.1) 3.39 (0.08)
1 Data presented as mean (± standard deviation) of relative abundance.
2 Animal diet groups are explained in Table 1.
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or if one of them is sufficient? This is a question that can be 
solved by applying the present screening model on animals 
given singular strains and then compare them with animals 
given the two strains together. However, this is outside 
the scope of the present study, but would be an important 
follow up study.
Several probiotic strains of the species L. fermentum and L. 
plantarum are commercially available. Two such examples 
are L. plantarum 299v and L. fermentum ME-3, respectively. 
The literature about the former are vast, and the strain 299v 
has, for example, been proved efficient to mitigate irritable 
bowel syndrome (Ducrotté et al., 2012; Nobaek et al., 2000). 
Strain 299v was also able to increase the diversity of the 
abundant microbiota on colonic mucosa in humans, after 
a four weeks intervention period (Karlsson et al., 2010). L. 
fermentum ME-3 has been shown to possess antimicrobial 
activity against intestinal pathogens and to have an 
outstanding high antioxidative activity (Mikelsaar and 
Zilmer, 2009). Generally speaking, the species L. plantarum 
and L. fermentum often occupy similar ecological niches 
in nature, they can both frequently be isolated from lactic 
acid fermented foods, but also from the gastro-intestinal 
tract of humans and animals. But, the two species are quite 
different, both when it comes to phenotype and genotype, 
so they can be expected to have different physiological and 
immunological effects in the gastro-intestinal tract. And 
perhaps, there could be advantages in combining strains 
of the two species in a probiotic mixture. Nevertheless, the 
LP-supplementation affected not only the viable count of 
lactobacilli (seen as an increase), and of Enterobacteriaceae 
(seen as a decrease), but resulted in a substantial increase 
in the proportion of lactobacilli in comparison with the 
total microbiota (Figure 3). No such effect was seen in the 
other Lactobacillus-supplemented groups.
5. Conclusions
The experimental animal model with equalised microbiota 
was proved suitable for in vivo studies on the effect of 
bacterial supplements on the microbiota. Supplementation 
with L. fermentum GOS47 and L. fermentum GOS1 and 
the mixture of L. fermentum GOS57 + L. plantarum 
GOS42 strongly affected the gut microbiota and increased 
diversity. Furthermore, the former combination may induce 
anti-inflammatory activity and SCFA production in the 
microbiota (inferred from 16S rRNA-gene compositional 
data), and the latter combination decreased the numbers 
of Enterobacteriaceae, and improved the abundance of 
lactobacilli. These two mixtures seem to have probiotic 
potential that call for further investigations.
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Figure 7. Extended error bar plot showing significantly different abundant KEGG pathways between CS-ctrl and LF. P-values are 
corrected with Bonferroni correction.
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